A key strength of our study is the high number of BRCA1/2 carriers, approximately 10 times higher than in the previous Danish BRCA1/2 cohort and considerably larger compared with other studies that examine the effects of BRRM on breast cancer incidence in BRCA1/2 cohorts [17, 19, 48]. Here, BRCA1 is linked to breast carcinoma.